🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In this study we will explore the combined effect of Brimonidine and Timolo...
Status
Unknown
Location
Carmel Medical Center
Start Date
2015-10
Trial ID
NCT02214680
Treatments Being Tested
The purpose of this study was to determine the incremental intraocular pres...
Status
Completed
Location
Novartis Investigative Site
Start Date
2017-09-21
Trial ID
NCT03150160
This study aims to compare the short-term effect of oxymetazoline 0.1% (Upn...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-01
Trial ID
NCT07390578
Treatments Being Tested
Laser-assisted cataract surgery is a common and precise procedure done to r...
Status
Completed
Location
Uptown Eye Speicialists
Start Date
2019-06-06
Trial ID
NCT04633954
Treatments Being Tested
This study evaluates the safety and efficacy of brimonidine 0.1% ophthalmic...
Status
Completed
Location
Multiple Locations
Start Date
2003-05
Trial ID
NCT00652483
Treatments Being Tested
The primary objective of this study is to compare the safety and efficacy o...
Status
Completed
Location
Alcon Call Center
Start Date
2003-01
Trial ID
NCT00061529
Treatments Being Tested
It is already known that the local treatment with Alphagan eye drops (a dru...
Status
Completed
Location
University of Basel, Dept. of Ophthalmology
Start Date
2011-06
Trial ID
NCT01201551
Treatments Being Tested
To compare the safety and tolerability of brimonidine tartrate ophthalmic s...
Status
Completed
Location
Bausch Site 3
Start Date
2014-02-22
Trial ID
NCT01959243
The purpose of this study is to determine the intraocular Pressure (IOP) lo...
Status
Completed
Location
Clinical Site
Start Date
2012-09
Trial ID
NCT01687426
Treatments Being Tested
This study evaluates the safety and efficacy of brimonidine 0.2%/timolol 0....
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00652106